INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference
Investors can watch a replay after the event or request a virtual meeting with management.
Rhea-AI Summary
INVO Fertility (IVF) will present at the virtual Lytham Partners Fall 2026 Investor Conference on September 29, 2026.
The webcast is scheduled for 11:30 a.m. ET. Management will also hold virtual one-on-one investor meetings during the September 29–30 conference. The company focuses on establishing, acquiring and operating fertility clinics and related businesses and technologies.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SARASOTA, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026.
Company Webcast
The webcast presentation will take place at 11:30 a.m. ET on Tuesday, September 29, 2026. The webcast can be accessed by visiting the conference website at https://lythampartners.com/fall2026/ or directly at https://app.webinar.net/Yy1V3pgKbZQ. The webcast will also be available for replay following the event.
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/fall2026invreg/.
About INVO Fertility
We are a healthcare services fertility company dedicated to expanding access to assisted reproductive technology ("ART") care to patients in need. Our principal commercial strategy is focused on building, acquiring, and operating fertility clinics and related businesses and technologies. Our acquisition strategy focuses on U.S.-based, profitable fertility clinics. Our clinics offer a variety of fertility services including in vitro fertilization ("IVF") and the intravaginal culture ("IVC") procedure enabled by INVOcell. We have four operational fertility clinics in the United States. We also continue to engage in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. For more information, please visit invofertility.com.
For more information, please contact:
INVO Fertility, Inc.
Steve Shum, CEO
978-878-9505
sshum@invofertility.com
Investor Contact
Lytham Partners, LLC
Robert Blum
602-889-9700
INVO@lythampartners.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How can investors watch INVO Fertility's conference webcast or request a meeting?
Investors can watch the webcast on the conference website or through the direct webcast link. To request a virtual one-on-one meeting with management, email 1x1@lythampartners.com or register for the event. A webcast replay will be available afterward.